Tirzepatide 45mg
Dual GIP / GLP-1 receptor agonist
≥99.0%
Third-Party
COA
Also available in 10mg · 15mg · 30mg · 60mg — compare all sizes
Complete your research kit
Also searched as: Tirz, GIP/GLP-1 dual agonist
Third-Party Tested
HPLC & mass spec verified purity
Batch Specific COA
Certificate with every batch
Discreet Packaging
Plain, unbranded, tamper-evident
Same-Day Dispatch
Before 2PM AEST, Australia-wide
Tirzepatide 45mg is a research compound supplied in lyophilised form for controlled laboratory and scientific investigation. Tirzepatide is a synthetic peptide designed to interact with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-receptor activity has made Tirzepatide 45mg relevant to experimental research examining incretin signalling, metabolic pathways and receptor pharmacology.
What Is Tirzepatide 45mg?
Tirzepatide is a single peptide compound rather than a blended formulation. It acts as a dual GIP and GLP-1 receptor agonist, allowing researchers to examine two related incretin signalling pathways within the same experimental framework.
The 45mg format provides a higher nominal quantity per vial for laboratory projects requiring additional material, while remaining chemically the same research compound as other Tirzepatide strengths.
Key Research Areas
Tirzepatide research has examined several areas of metabolic and endocrine biology, including:
Findings should always be interpreted according to the experimental model and study design rather than assumed to represent established outcomes.
Why Researchers Study Tirzepatide
A major scientific feature of Tirzepatide is its ability to activate two incretin receptors. GLP-1 and GIP participate in overlapping but distinct biological signalling processes.
Studying a dual agonist enables researchers to investigate how simultaneous receptor activation differs from isolated GLP-1 or GIP signalling and to explore interactions between these pathways under controlled experimental conditions.
Key Research Areas at a Glance
Tirzepatide 45mg Australia
Researchers looking for Tirzepatide 45mg Australia should verify current stock status, price, analytical testing and CoA documentation before ordering. Australian shipping and dispatch information should also be confirmed from the supplier’s current product information.
Specifications
Certificate of Analysis
Quality, Purity and Batch Testing
Tirzepatide 45mg should be assessed according to its batch-specific analytical documentation. Where provided, HPLC can help evaluate chromatographic purity, while LC-MS or mass spectrometry can support compound identity and molecular-characterisation work.
Researchers should consult the applicable Certificate of Analysis (CoA) rather than assuming that analytical results from another strength or batch apply to the 45mg product.
Storage & Handling
Storage and Laboratory Handling
- Lyophilised storage: Follow the storage conditions stated on the product label and batch documentation.
- After reconstitution: Follow validated laboratory protocols and batch-specific information. A post-reconstitution stability period should not be assumed where supporting stability data have not been provided.
Reconstitution calculator: Tirzepatide 45mg
Work out concentration and the volume to draw for each aliquot before you add diluent.
- Concentration
- –
- Volume per aliquot
- –
- On a 1 mL (U-100) syringe
- –
- Aliquots per vial
- –
A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.
Tirzepatide 45mg: Frequently Asked Questions
It is a 45mg research format of the dual GIP/GLP-1 receptor agonist Tirzepatide.
It activates GIP and GLP-1 receptors, enabling investigation of incretin-related signalling.
It allows researchers to examine interactions between two distinct incretin pathways.
Research includes metabolic, endocrine, receptor and cellular signalling pathways.
Refer to the specific batch documentation for verified purity data.
Availability should be confirmed for the individual product batch.
Follow verified label, CoA and laboratory storage documentation.
Check the supplier's current Australian availability, stock, price and shipping information.
No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.
Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.
Purchase Other Quantities
Tirzepatide is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.
Reviews
There are no reviews yet.